STRUCTURE AND TRAFFICKING OF PCSK9 IN LDL BINDING

被引：0
|
作者：
Matteucci, Sara [1 ]
Pravata, Valentina [1 ]
Esposito, Francesco Maria [1 ]
Arnaboldi, Lorenzo [2 ]
Gianazza, Erica [3 ]
Grigore, Liliana [1 ]
Banfi, Cristina [3 ]
Catapano, Alberico [1 ]
机构：
[1] IRCCS Multimed, Milan, Italy
[2] Univ Milan, Dept Pharmacol Sci Rodolfo Paoletti Disfeb, Milan, Italy
[3] IRCCS Monzino Cardiol Ctr, Milan, Italy
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P220
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BINDING OF PCSK9 TO CIRCULATING LDL: EFFECT OF PCSK9 MONOCLONAL ANTIBODIES ON THE LDL-BOUND PCSK9?
    De Stefano, D.
    Baragetti, A.
    Baragetti, A.
    Macri, N.
    Tavori, H.
    Fazio, S.
    Catapano, A. L.
    ATHEROSCLEROSIS, 2018, 275 : E101 - E101
  • [2] A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove
    Evison, Benny J.
    Palmer, James T.
    Lambert, Gilles
    Treutlein, Herbert
    Zeng, Jun
    Nativel, Brice
    Chemello, Kevin
    Zhu, Qing
    Wang, Jie
    Teng, Yanfen
    Tang, Wei
    Xu, Yanfeng
    Rathi, Anuj Kumar
    Kumar, Sanjay
    Suchowerska, Alexandra K.
    Parmar, Jasneet
    Dixon, Ian
    Kelly, Graham E.
    Bonnar, James
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (06)
  • [3] New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic Peptide
    Landmesser, Ulf
    Makhmudova, Umidakhon
    CIRCULATION, 2023, 148 (02) : 159 - 161
  • [4] PCSK9 inhibitors for LDL lowering
    Walsh, Lames P.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (07) : 575 - 577
  • [5] PCSK9 and atherosclerosis: beyond LDL
    Catapano, A. L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 28 - 28
  • [6] PCSK9 and LDLR trafficking in hepatocytes
    Zhang, Da-Wei
    Garuti, Rita
    Lagace, Tom
    Horton, Jay
    Cohen, Jonathan C.
    Hobbs, Helen H.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E115 - E115
  • [7] A PCSK9 C-terminal Domain Binding Fab Inhibits PCSK9 Internalization and Restores LDL-uptake
    Ni, Yan G.
    Condra, Jon H.
    Di Marco, Stefania
    Orsatti, Laura
    Shen, Xun
    Pandit, Shilpa
    Bottomley, Matthew J.
    Ruggeri, Lionello
    Cummings, Richard T.
    Cubbon, Rose M.
    Santoro, Joseph C.
    Fisher, Timothy S.
    Lo Surdo, Paola
    Talamo, Fabio
    Wood, Dana D.
    Hammond, Holly A.
    Wisniewski, Douglas
    Volpari, Cinzia
    Njimoluh, Leila
    Ha, Sookhee
    Hubbard, Brian
    Carfi, Andrea
    Sitlani, Ayesha
    CIRCULATION, 2009, 120 (18) : S477 - S477
  • [8] PCSK9: a convertase that coordinates LDL catabolism
    Horton, Jay D.
    Cohen, Jonathan C.
    Hobbs, Helen H.
    JOURNAL OF LIPID RESEARCH, 2009, 50 : S172 - S177
  • [9] PCSK9 antibody reduces LDL cholesterol
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2012, 11 : 11 - 11
  • [10] The crystal structure of PCSK9: A regulator of plasma LDL-cholesterol
    Piper, Derek E.
    Jackson, Simon
    Liu, Qiang
    Romanow, William G.
    Shetterly, Susan
    Thibault, Stephen T.
    Shan, Bei
    Walker, Nigel P. C.
    STRUCTURE, 2007, 15 (05) : 545 - 552
12345